3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
2
Not yet recruiting
1
Completed
1
Sponsor Class
OTHER
72
INDUSTRY
10
UNKNOWN
5
OTHER_GOV
2
NETWORK
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Breast
2
Conditions
Breast Neoplasms
2
Pathologic Complete Response
1
Interventions
apatinib
25
Cisplatin
19
Capecitabine
17
Irinotecan
16
Cyclophosphamide
16
fludarabine
14
Radiotherapy
12
Oxaliplatin
12
Drug Therapy
12
camrelizumab
11
Paclitaxel
11
S 1 (combination)
10
Docetaxel
10
Carboplatin
10
Fluorouracil
9
Blood Specimen Collection
9
Bevacizumab
9
Nivolumab
8
tislelizumab
7
Radiation
7
Pemetrexed
7
Gemcitabine
7
Erlotinib Hydrochloride
7
Surgical Procedures, Operative
6
Neoadjuvant Therapy
6
Albumin-Bound Paclitaxel
6
toripalimab
5
anlotinib
5
XELOX
5
Tamoxifen
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
OTHER_GOV
×
130-nm albumin-bound paclitaxel
×
Clear all
NCT05953909
2023-07-20
ERI-Based-01
Fujian Cancer Hospital
Unknown
120 enrolled
NCT01830244
2017-07-02
Neonab
Barwon Health
Phase 2
Unknown
60 enrolled